ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading&nbsp ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading 

Posted on by Raj Gaurav Rai

ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading&nbsp ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading 

Please follow and like us:

Related Posts

NTPC gets board approval for raising of Rs 12,000 crore via bonds, NCDS NTPC recently told analysts in a concall that it has various capital expenditure projects such as ongoing projects and new capacity addition programs NTPC gets board approval for raising of Rs 12,000 crore via bonds, NCDS NTPC recently told analysts in a concall that it has various capital expenditure projects such as ongoing projects and new capacity addition programs

NTPC gets board approval for raising of Rs 12,000 crore via bonds, NCDS NTPC recently told analysts in a concall that it has various capital […]

Exit mobile version